These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6261377)

  • 21. [Myoclonic encephalopathy due to ingestion of insoluble salts of bismuth].
    Cambier J; Dairou R
    Arch Fr Mal App Dig; 1975; 64(1):5-9. PubMed ID: 1164144
    [No Abstract]   [Full Text] [Related]  

  • 22. [Bismuth encephalopathy. Presentation of a case].
    Fernández Barreiro A; Sicilia Guillén J; Castejón Vera P; Escribano Soriano JB; Bautista Prados JG; Díaz Ortuño A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1983; 11(2):127-32. PubMed ID: 6880891
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bismuth myoclonic encephalopathies. Their course and lasting or definitive late complications].
    Buge A; Rancurel G; Dechy H
    Rev Neurol (Paris); 1977; 133(6-7):401-15. PubMed ID: 929035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Epidemiological aspects of the encephalopathies resulting from oral administration of bismuth (author's transl)].
    Martin-Bouyer G; Foulon B; Guerbois H; Barin C
    Therapie; 1980; 35(3):307-13. PubMed ID: 7423418
    [No Abstract]   [Full Text] [Related]  

  • 25. [Bismuth associated myoclonic encephalopathy: is a prevention possible? (author's transl)].
    Grandjean EM
    Schweiz Rundsch Med Prax; 1977 Jan; 66(3):59-61. PubMed ID: 834718
    [No Abstract]   [Full Text] [Related]  

  • 26. Myoclonic encephalopathy caused by chronic bismuth abuse.
    Teepker M; Hamer HM; Knake S; Bandmann O; Oertel WH; Rosenow F
    Epileptic Disord; 2002 Dec; 4(4):229-33. PubMed ID: 12600808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus.
    Gordon MF; Abrams RI; Rubin DB; Barr WB; Correa DD
    Mov Disord; 1995 Mar; 10(2):220-2. PubMed ID: 7753066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bismuth salts used in gastro-enterology. Data from animal investigations (author's transl)].
    Bouvet P
    Ann Pharm Fr; 1981 Feb; 38(5):447-54. PubMed ID: 7011157
    [No Abstract]   [Full Text] [Related]  

  • 29. [Study of the bismuth effect on bacteria, specially on faecal flora (author's transl)].
    Joly B; Petit S; Laveran H; Cluzel R
    Ann Pharm Fr; 1980; 38(1):75-80. PubMed ID: 7396344
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bismuth-induced encephalopathy].
    Caron JC; Prudhomme M; Warot P
    Lille Med; 1977 Feb; 22(2):98-100. PubMed ID: 865243
    [No Abstract]   [Full Text] [Related]  

  • 31. [Rare observation of a humerus head necrosis (author's transl)].
    Podesva K; Ritter H
    Unfallheilkunde; 1982 Mar; 85(3):120-2. PubMed ID: 7090086
    [No Abstract]   [Full Text] [Related]  

  • 32. Muscle pedicled bone graft in revascularization of aseptic necrosis of the humeral head.
    Rindell K
    Ann Chir Gynaecol; 1987; 76(5):283-5. PubMed ID: 3324919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The relationship between the course of bismuth encephalopathy and the amount of bismuth in blood and urine].
    Boiteau HL; Cler JM; Mathé JF; Delobel R; Fève J
    Eur J Toxicol Environ Hyg; 1976; 9(4):233-9. PubMed ID: 976332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bismuth preparations--encephalopathy].
    Myren J; Sigstad H
    Tidsskr Nor Laegeforen; 1978 Feb; 98(6):333. PubMed ID: 635868
    [No Abstract]   [Full Text] [Related]  

  • 35. [Semiology of bismuth encephalopathy. Comparison with seven personal cases (author's transl)].
    Collignon R; Bruyer R; Rectem D; Indekeu P; Laterre EC
    Acta Neurol Belg; 1979; 79(2):73-91. PubMed ID: 484202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Encephalopathy during oral treatment with bismuth salts].
    Michaud PA; Regli F
    Schweiz Med Wochenschr; 1976 Apr; 106(16):550-5. PubMed ID: 988634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Psychiatric aspects of encephalopathy caused by bismuth salts].
    Bertaud M; Mangin P; Charlin A
    Ann Med Psychol (Paris); 1976 May; 1(5):717-21. PubMed ID: 970827
    [No Abstract]   [Full Text] [Related]  

  • 38. [Encephalopathy caused by ingestion of bismuth salts].
    Aerts J
    Arch Belg Med Soc; 1976 Oct; 34(8):517-25. PubMed ID: 1028385
    [No Abstract]   [Full Text] [Related]  

  • 39. [Encephalopathy after oral ingestion of bismuth salt over a short time period (10 days)].
    Davous P; Bouche P; Derouesne C; Castaigne P
    Nouv Presse Med; 1977 Oct; 6(36):3336. PubMed ID: 593865
    [No Abstract]   [Full Text] [Related]  

  • 40. [Letter: Myoclonic encephalopathies caused by bismuth salts].
    Tournilhac M; Flori B; Dordain G; Roye JM
    Nouv Presse Med; 1975 Feb; 4(6):430. PubMed ID: 1129100
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.